| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |